Tirzepatide | 30mg / 2mL

Tirzepatide is a novel dual agonist peptide that targets both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. By enhancing insulin secretion and reducing glucagon levels (a hormone responsible for regulating glucose production in the liver), tirzepatide helps improve glucose regulation and metabolic function.

Weight Loss Benefits:

• Appetite Suppression: Tirzepatide activates GLP-1 receptors in the hypothalamus, the brain region responsible for appetite regulation. This leads to increased satiety and reduced hunger, which is a primary mechanism contributing to weight loss.

• Delayed Gastric Emptying: The activation of GLP-1 receptors by tirzepatide also slows gastric emptying, thereby reducing the rate at which nutrients are absorbed. This effect promotes prolonged fullness, reducing caloric intake and supporting weight loss.

• Improved Lipid Metabolism: Tirzepatide stimulates GIP receptors located in adipose tissue, liver, and other peripheral tissues, enhancing lipid metabolism. This results in decreased fat storage and increased utilization of stored fat for energy, contributing to weight loss.

• Enhanced Glucose Homeostasis: As a dual agonist, tirzepatide improves glucose homeostasis by promoting insulin secretion in response to food intake and suppressing glucagon secretion. This balanced glucose regulation helps optimize energy usage and reduces the risk of insulin resistance and weight gain.

• Reduced Inflammation: Emerging studies suggest that tirzepatide may reduce inflammation, which is commonly associated with obesity and metabolic disorders. By lowering inflammation, tirzepatide may create a more favorable metabolic environment for weight loss.

The weight loss benefits of tirzepatide have been demonstrated in clinical trials involving patients with type 2 diabetes, where participants experienced significant weight reductions compared to those receiving other antidiabetic medications or placebo. The dual agonist mechanism of tirzepatide, targeting both GLP-1 and GIP receptors, plays a crucial role in its potent weight loss effects.

Content & Potency:

Injectable Formulation:

• 10mg Lyophilized Peptide (provided in a vial)

Reconstitution Instructions:
Reconstitute each vial with 1mL of Bacteriostatic Water*
(*Bacteriostatic water is sold separately.)